These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6296361)

  • 1. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat.
    Gillis RA; Quest JA; Pagani FD; Souza JD; Da Silva AM; Jensen RT; Garvey TQ; Hamosh P
    J Pharmacol Exp Ther; 1983 Feb; 224(2):408-14. PubMed ID: 6296361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin stimulates neuronal receptors to produce contraction of the canine colon.
    Barone FC; Bondinell WE; Labosh TJ; White RF; Ormsbee HS
    Life Sci; 1989; 44(8):533-42. PubMed ID: 2927258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amylin on feeding of goldfish: interactions with CCK.
    Thavanathan R; Volkoff H
    Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
    Romański KW
    J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of CCK1 receptors to cardiovascular and respiratory effects of cholecystokinin in anesthetized rats.
    Kaczyńska K; Szereda-Przestaszewska M
    Neuropeptides; 2015 Dec; 54():29-34. PubMed ID: 26342277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of cholecystokinin-octapeptide on sphincter of Oddi basal pressure and phasic wave activity in humans.
    Toouli J; Hogan WJ; Geenen JE; Dodds WJ; Arndorfer RC
    Surgery; 1982 Sep; 92(3):497-503. PubMed ID: 6287657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cholecystokinin-octapeptide on lower esophageal sphincter.
    Behar J; Biancani P
    Gastroenterology; 1977 Jul; 73(1):57-61. PubMed ID: 863201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholecystokinin octapeptide on rat cardiac function and the receptor mechanism.
    Zhao XY; Ling YL; Meng AH; Shan BE; Zhang JL
    Sheng Li Xue Bao; 2002 Jun; 54(3):239-43. PubMed ID: 12075472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apneic effects of cholecystokinin in unanaesthetized fetal sheep.
    Bennet L; Johnston BM; Gluckman PD
    J Dev Physiol; 1990 Oct; 14(4):229-33. PubMed ID: 2099380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of octapeptide of cholecystokinin, vasoactive intestinal peptide and substance P on dynamics of biliary system and cardiovascular system].
    Zhang J; Zou S; Qiu F
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):48-51. PubMed ID: 10374510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of octapeptide of cholecystokinin, vasoactive intestinal peptide and substance P on dynamics of biliary system and cardiovascular system.
    Zou S; Zhang J; Qiu F
    Chin Med J (Engl); 1998 Dec; 111(12):1071-4. PubMed ID: 11263366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action.
    Behar J; Biancani P
    J Clin Invest; 1980 Dec; 66(6):1231-9. PubMed ID: 7440712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
    J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentobarbital causes cardiorespiratory depression by interacting with a GABAergic system at the ventral surface of the medulla.
    Yamada KA; Moerschbaecher JM; Hamosh P; Gillis RA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):349-55. PubMed ID: 6875848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholecystokinin-octapeptide antagonizes the central depressive effect of opioid peptides in rats].
    Mei L; Han JS
    Sheng Li Xue Bao; 1991 Apr; 43(2):156-63. PubMed ID: 2068585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
    Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.